Syndax grants stock options for 175,000 shares to 19 new employees under inducement plan
SNDX•Inducement stock options granted to new employees
Syndax Pharmaceuticals granted inducement stock options for up to 175,000 common shares to 19 new employees on Sept. 1, 2026.
The awards were issued under the company’s 2023 Inducement Plan.
The vesting schedule runs four years, with 25% vesting after one year. The remaining shares vest monthly at 1/48 over the next 36 months, contingent on continued service.
